Vita Life Sciences (ASX: VLS) is an Australian-listed company in the Healthcare sector with a market capitalisation of $138.3M and the 752nd-largest security on the ASX by market capitalisation. The VLS share price is $2.55, up 4.94% today and up 23.06% over the past 12 months. Shares have traded between $2.05 and $2.84 over the past 52 weeks. VLS trades on a price-to-earnings ratio of 6.43, below the Healthcare sector median of 14.96, and pays a trailing dividend yield of 1.72%. In its most recent reported period (ending 31 Dec 2025), Vita Life Sciences reported revenue of $47.7M and a net profit of $5.6M (11.7% margin).
About Vita Life Sciences Limited
Vita Life Sciences Limited is an Australian healthcare company specializing in the formulation, packaging, distribution, and sale of vitamins and nutritional supplements. The company's reach spans Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. In addition to core supplements, their product range encompasses minerals, various herbs, and superfoods. They offer solutions targeting a broad spectrum of therapeutic areas, including nervous system support, general nutrition, immunity, hair, skin, and nails, liver and digestion, weight management, cardiovascular health, pain and inflammation, pregnancy and breastfeeding, and health specifically for men, women, and children. Products also provide antioxidant benefits and support for bones and joints. Marketed under their prominent brands—Herbs of Gold, VitaHealth, and VitaScience—these offerings are sold through pharmacies and health food channels. Established in 1947, Vita Life Sciences Limited is headquartered in Kirrawee, Australia.
